Diagnostic agents for positron emission imaging using...

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001110, C424S001650, C424S001810, C424S001850, C424S009400, C424S009100, C424S009450, C424S009451

Reexamination Certificate

active

11049797

ABSTRACT:
New diagnostic agents for positron emission tomography (PET) and methods for use of such agents for imaging of human or animal tissue are described, wherein a primary active component of such agents is a radiolabeled halogenated xanthene or halogenated xanthene derivative. Preferably, the radiolabeled halogenated xanthene is radiolabeled Rose Bengal or a functional derivative of Rose Bengal.

REFERENCES:
patent: 4577636 (1986-03-01), Spears
patent: 5171563 (1992-12-01), Abrams et al.
patent: 5240693 (1993-08-01), Born et al.
patent: 6493570 (2002-12-01), Dees et al.
patent: 846674 (1960-08-01), None
PCT International Search Report and Written Opinion for PCT/US05/16836 dated Nov. 17, 2005.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic agents for positron emission imaging using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic agents for positron emission imaging using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic agents for positron emission imaging using... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3908838

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.